RUBRA MEDICAMENTS LTD. - Statement Of Investor Complaints For The Quarter Ended March 31, 2017

Pursuant to Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Investor Grievance Redressal Report for the Quarter ended March 31, 2017 is as follows: DETAILS OF INVESTOR COMPLAINTS Pending at the beginning of the quarter Nil Received during the quarter Nil Disposed of during the quarter Nil Remaining unresolved at the end of the quarter Nil Please take note of the same.